Ｍ－リボミック：RIBOMIC Announces Completion of 50% of Enrollment of its Phase 2 Clinical Trial for Wet Age-Related Macular Degeneration (TOFU Study) - 有報キャッチャー

Ｍ－リボミック（4591）　RIBOMIC Announces Completion of 50% of Enrollment of its Phase 2 Clinical Trial for Wet Age-Related Macular Degeneration (TOFU Study) 2021/02/01

/-

読み込み中…